Talking Biotech with Dr. Kevin Folta
Science:Life Sciences
Overcoming CAR-T Cell Bottlenecks - Dr. Andy Scharenberg
Immunotherapy is weaponizing the body's immune system against cancer or other disease. One of the most promising approaches is CAR-T cell therapy, yet as this technology has been implemented, it's limitations have been identified. Dr. Andy Scharenberg described the current drawbacks of CAR-T cells and how his company, Umoja, is re-engineering CAR-T cells in vivo to create more effective therapies, including approaches that can address solid tumors. Co-hosted by Donald Coon.
www.umoja-biopharma.com
More Episodes
2020-02-08
2020-01-25
2020-01-18
2020-01-11
2020-01-04
2019-12-21
2019-12-14
2019-12-07
2019-11-30
2019-11-23
2019-11-16
2019-11-09
2019-11-02
2019-10-26
2019-10-19
2019-10-12
2019-10-05
2019-09-28
Get this podcast on your
phone, FREE
